Vectura integrates formulation, device and development capabilities to offer a broad range of services to help customers bring inhaled medicines to market.

Vectura offers comprehensive services from the pre-clinical stage of development, when customers are looking to overcome complex inhaled formulation challenges, select a delivery device and move quickly to the clinic. With expertise in powder and liquid formulations, as well as a portfolio of proprietary device and formulation technologies, Vectura can help customers developing a wide range of small molecules, biologics and complex combinations. 

Optimising drug formulation and delivery device development can unlock the potential for innovative inhaled medicines that can revolutionise patients’ lives. Vectura is at the forefront of integrated drug and device development, and helping customers to deliver the inhaled therapies of the future. 

  • GB
  • 2020
    On CPHI since
  • 250 - 499
Company types
Contract Service
Contact info
  • One Prospect West, Chippenham, Wiltshire, SN14 6FH, Wiltshire, United Kingdom
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

Products from VECTURA GROUP PLC (5)

  • Inhalation Device Platforms

    Product Inhalation Device Platforms

    Access the delivery technology best suited to the needs of your development programme, including unit-dose and multi-unit dose DPIs, pMDIs and smart nebulisers, suitable for home or hospital applications.

    Dry Powder Inhalers:
    Options include proprietary unit- and multi-unit dose platforms, as well...
  • Inhaled Formulation Development

    Product Inhaled Formulation Development

    With expertise in powder and liquid formulations for small molecules and biologics, as well as a broad portfolio of proprietary device and formulation technologies, we can help you overcome the challenges of inhaled formulation development.

    Dry Powder Formulation
    Advanced powde...
  • Analytical Services - Inhaled Products

    Product Analytical Services - Inhaled Products

    With extensive, state-of-the-art analytical testing facilities and equipment, our expert teams are able to develop and validate the methodologies required to characterise inhaled delivery platforms, especially DPI, pMDI and nebulised products.

    To ensure seamless support for your development, w...
  • Process Development & Inhaled Product Manufacturing

    Product Process Development & Inhaled Product Manufacturing

    In addition to extensive development manufacturing facilities, Vectura has GMP manufacturing facilities for dry powder inhalers, pMDI and nebuliser medical devices as well as further capability to handle biological molecules. 

    Our GMP manufacturing facilities and equipment are relevant-to-commerci...
  • Medical & Regulatory Services - Inhaled Products

    Product Medical & Regulatory Services - Inhaled Products

    Our formulation, device and development services are supported by our medical, regulatory, device vigilance and pharmacovigilance teams to safeguard your programme and ensure the smoothest path to product approval.

    Our in-house team can support with:

    Global regulatory development strategy an...